Related Experiment Videos
Fatal meningitis with group JK Corynebacterium in a leukopenic patient
European Journal of Clinical Microbiology
|June 1, 1983
Abstract:
A case of fatal meningitis and septicemia with group JK Corynebacterium species in a leukopenic patient is reported. The strain was susceptible to rifampicin and vancomycin only. The finding of diphtheroids in bacteriological samples from immunocompromised patients should not be ignored. The literature regarding meningitis caused by diphtheroid bacilli is reviewed.
Insights
Group JK Corynebacterium caused fatal meningitis and septicemia in a leukopenic patient. This finding highlights the importance of identifying diphtheroids in immunocompromised individuals, as treatment options may be limited.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Clinical Pathology
Background:
- Diphtheroid bacilli, including Corynebacterium species, are often considered commensals but can cause opportunistic infections.
- Leukopenia, a reduced white blood cell count, significantly increases susceptibility to severe bacterial infections.
- Meningitis and septicemia are life-threatening conditions requiring prompt diagnosis and targeted antimicrobial therapy.
Observation:
- A case of fatal meningitis and septicemia is presented in a patient with leukopenia.
- The causative agent was identified as a group JK Corynebacterium species.
- The isolate exhibited a limited susceptibility profile, being sensitive only to rifampicin and vancomycin.
Findings:
- Group JK Corynebacterium can be a virulent pathogen, leading to severe invasive infections like meningitis and septicemia.
- Antimicrobial susceptibility testing is crucial for guiding treatment, as resistance patterns can vary.
- The case underscores the potential pathogenicity of diphtheroids in immunocompromised hosts.
Implications:
- Clinicians should maintain a high index of suspicion for diphtheroid infections, particularly Corynebacterium species, in leukopenic or immunocompromised patients.
- Diagnostic laboratories must accurately identify diphtheroids from clinical specimens.
- Effective management strategies may require early recognition and specific antibiotic choices, such as rifampicin and vancomycin, based on susceptibility data.